In Practice: Nominations open for RACGP Awards GPs, supervisors, GPs in training and general practices are recognised for outstanding work on the healthcare frontline.
RSV vaccine approved for use in at-risk over-50s The new TGA approval allows access to the Arexvy vaccine for at-risk adults aged 50–59, expanding the previous indication.
In Practice: Be prepared for 2025 flu season With flu season approaching, ATAGI is reminding GPs to keep up to date with the latest vaccine advice and resources.
First Arexvy safety data released The Australian-first safety data found 63% of recipients experienced no side effects in the first three days after vaccination.
WHO launches global encephalitis policy The release comes as one GP expert says ‘it’s very likely that Japanese encephalitis is now endemic in Australia’.
New cervical screening guidelines broaden self-collect options The incoming guidelines bring simplification ‘without compromising quality and safety’ and increase the role of self-collection.
Japanese encephalitis virus spreads to new areas With the virus detected in NSW and Victoria and the season’s first human case, GPs should be prepared for patients asking about protection.
Free RSV vaccination for Qld pregnant women Queensland’s expectant mothers are now eligible for a subsidised Abrysvo vaccination, as the state’s RSV cases soar to 40,000 in 2024.
RSV vaccine added to national program To ensure ‘every single infant in Australia is protected’, a $174.5 million investment will see free vaccines for pregnant people available nationwide.
Victoria subsidises RSV immunisations for babies The State Government will fund the long-acting monoclonal antibody for unprotected newborns and eligible infants next winter.